Described here are methods for forming tracts in tissue. More specifically, described here are methods for forming tracts in tissue, where at least a portion of the tissue has been deformed.
A number of devices and methods have previously been described for forming tracts in or through tissue. For example, U.S. patent application Ser. Nos. 10/844,247, 11/544,196, 11/545,272, 11/544,365, 11/544,177, 11/544,149, 10/888,682, 11/432,982, 11/544,317, 11/788,509, all of which are incorporated by reference in their entirety herein, describe devices and methods for forming tracts in tissue. In general, the tracts described there self-seal or seal without the need for a supplemental closure device. These tracts may be quite useful in providing access to a tissue location (e.g., an organ lumen) so that one or more tools may be advanced through the tract, and a procedure may be performed. Given the tremendous applicability of such methods, additional methods of forming tracts in tissue would be desirable.
Described here are methods for forming one or more tracts in tissue. The tracts may be formed in any suitable or desirable tissue. For example, the tissue may be an organ of any of the body systems, (e.g., the cardiovascular system, the digestive system, the respiratory system, the excretory system, the reproductive system, the nervous system, etc.). In some variations, the tissue is an organ of the cardiovascular system, such as the heart or an artery. In other variations, the tissue is an organ of the digestive system, such as the stomach or intestines. The tracts formed here may seal relatively quickly without the need for a supplemental closure device. For example, the tracts may seal within 12 minutes or less, within 9 minutes or less, within 6 minutes or less, within 3 minutes or less, etc. Of course, if necessary or desirable, a supplemental closure device may be used in conjunction with the described methods.
In some variations, the methods comprise advancing a tissue-locating member adjacent to a tissue wall, deforming at least a portion of the tissue wall with the tissue-locating member, and advancing a tissue-piercing member through the deformed tissue to form the tract, wherein the tract provides access for one or more tools. In some variations, deforming at least a portion of the tissue comprises changing the orientation of the tissue wall from a first configuration to a second configuration (e.g., by changing the shape of the tissue wall, etc.). In other variations, deforming at least a portion of the tissue comprises changing the position of the tissue wall (e.g., by rotating or tenting the tissue).
The methods may further comprise deforming at least a portion of the tissue after the tissue-piercing member has been advanced, where deforming the tissue comprises changing the orientation of the tissue wall from a second configuration to a third configuration. A tissue-piercing member may then optionally be advanced through the deformed tissue in the third configuration, affecting needle redirection.
The tract may be of any suitable or desirable length. In some variations, the tissue-piercing member enters the tissue at a first location, and exits the tissue at a second location, and the length between the first location and the second location is greater than the thickness of the tissue wall. In some variations, the length of the tract is greater than the thickness of the tissue wall.
One or more tools may be advanced through the tract, e.g., a wire, a sheath, a catheter, a cutting device, an ablation device, one or more implants, or any other tool.
In some variations, advancement of a tool through the tract increases the diameter, cross-sectional area, perimeter, or general width of the tract.
The methods described here may also be used with tissue having at least one irregular surface. In general, methods of forming a tract in a tissue having at least one irregular tissue surface comprise advancing a tissue-locating member adjacent to a tissue wall, reshaping at least a portion of the tissue wall, wherein the tissue wall has an irregular surface, and advancing a tissue-piercing member through the reshaped tissue to form the tract, where the tract provides access for one or more tools. Similarly, methods for forming tracts in tented or rotated tissue are specifically described. In general, the methods for forming a tract in tented tissue comprise advancing a tissue-locating member adjacent to a tissue wall, tenting at least a portion of the tissue wall, and advancing a tissue-piercing member through the tented tissue to form the tract, wherein the tenting immobilizes at least a portion of the tissue wall during advancement of the tissue-piercing member therethrough.
The methods for forming a tract in rotated tissue generally comprise advancing a tissue-locating member adjacent to a tissue wall, rotating at least a portion of the tissue wall, and advancing a tissue-piercing member through the rotated tissue to form the tract, where the rotating helps position the tissue-piercing member relative to the tissue wall. Any of the methods described here may also comprise immobilizing at least a portion of the tissue.
Described here are methods for forming tracts in tissue, and in general, the tracts formed by the methods described here seal relatively quickly without the need for a supplemental closure device. In some variations the methods comprise forming a tract in tissue by advancing a tissue-locating member adjacent a tissue wall, deforming at least a portion of the tissue wall with the tissue-locating member, and advancing a tissue-piercing member through the deformed tissue to form the tract, where the tract provides access for one or more tools. Deforming at least a portion of tissue may comprise changing the tissue wall from a first configuration to a second configuration, e.g., by changing the shape, position, etc. In some variations, deforming at least a portion of tissue comprises rotating the tissue. In other variations, deforming at least a portion of tissue comprises tenting the tissue. At least a portion of the tissue may be immobilized during the formation of a tract, as will be described in more detail below.
It should be understood that the methods described here may be used with any desirable tissue. For example, the tissue may be an organ, such as an organ of any of the body systems (e.g., cardiovascular system, respiratory system, excretory system, digestive system, reproductive system, nervous system, etc.). In some variations, the methods are used with tissue of the cardiovascular system, such as the vasculature or the heart. In some variations, the tissue is an artery, and the methods are used in conjunction with performing an arterial puncture. In other variations, the tissue is an organ of the digestive system, such as the stomach, or intestines.
Shown in
In the variation shown in
The device may have one or more levers for any suitable purpose. For example, the lever (414) shown in
Also shown in
Also shown in
Any suitable materials for the device (400) may be used. For example, it may be comprised of one or more biocompatible plastic materials (e.g., an injection molded polycarbonate), stainless steels, shape memory materials, combinations thereof, or any other suitable materials. Other suitable devices for use with the methods described herein are disclosed in detail in Applicant's previous applications, which were incorporated by reference herein, above.
The distal end of needle guide (417) has been advanced slightly into the lumen (104) to expose opening (419) to blood flowing through lumen (104). The needle guide (417) is in fluid communication with the marker port (420), so that blood entering opening (419) may exit through marker port (420) indicating that the needle guide has been correctly positioned in the lumen (104) as noted above (and shown by 900).
As shown in
As shown in
Also described here are methods of forming tracts in rotated tissue. In some variations, these methods comprise, advancing a tissue-locating member adjacent to a tissue wall, rotating at least a portion of the tissue wall, and advancing a tissue-piercing member through the rotated tissue to form the tract, wherein the rotating helps to position the tissue-piercing member relative to the tissue wall. Tissue rotation may be particularly desirable, e.g., when the initial Seldinger stick is performed off the center-axis.
In this way, rotation of the tissue may be useful to effect a desirable tissue-piercing member location, which may in turn be useful for forming a tract having suitable thicknesses of tissue on either side. This may help ensure that the tract is robust enough to withstand repetitive insertion of various tools. In addition, having sufficient tissue thickness on either side of the tract may help the tract seal more quickly. Initial positioning of the tissue-piercing member away from one or more surfaces of the tissue wall may also help with the formation of a longer tract, which may also be useful in ensuring more rapid sealing.
Of course, rotation of the tissue may be used in combination with any other method of tissue deformation described herein. For example,
The tissue may be rotated in either direction about a tissue circumference (e.g., from 0.degree.-360.degree., from 0.degree.-180.degree., from 0.degree.-45.degree., from 45.degree.-90.degree., etc.). However, the tissue need not be rotated a significant amount (e.g., the tissue may be rotated 1.degree., 5.degree., 10.degree., 15.degree., etc.) and the entire tissue thickness need not be rotated. For example, in some instances it may be desirable to rotate only the tissue nearest the tissue-locating member, etc.
Also described here are methods for forming tracts in a tissue having an irregular tissue surface. In some variations, the methods comprise advancing a tissue-locating member adjacent a tissue wall, reshaping at least a portion of the tissue wall, wherein the tissue wall has an irregular surface, and advancing a tissue-piercing member through the reshaped tissue to form the tract, where the tract provides access for one or more tools.
In
Arterial punctures were performed in 28 patients using the device shown in
When the exit port of the guide cannula reached the skin surface, the guidewire was removed. The device was then rotated ¼ turn to the right or left to ease the advancement of the tissue-locating member into the artery. The device was then advanced further into the vessel, until a blood flash was observed from the marker port. The actuator was then engaged (to deploy a retainer) and gentle traction was applied to the handle until blood flash from the marker port shut off, indicating that the tissue-locating member was properly positioned against the artery wall. The plunger was then advanced to its stop, and the lever was actuated. The stop was then removed and the plunger was advanced to its maximum distance. A flash of blood was observed out of the plunger proximal opening, indicating that the tissue-piercing member had entered the lumen. The 0.14″ guide wire was then advanced through the plunger and tissue-piercing member into the artery lumen. The plunger port was then retracted. The retainer was then released, and the device was removed. A 6FR procedural sheath was then advanced over the 0.14″ guidewire. Contrast injection under fluoroscopy was then optionally performed to visualize the insertion site, followed by an inspection for damage. A percutaneous procedure was then performed. After the procedure, pressure was held at the sheath insertion site and the procedural sheath was removed. Pressure was held for 1 minute. After 1 minute, pressure was released and the site was inspected for signs of arterial bleeding. If bleeding was noted, pressure was held for an additional 1 minute and the site was then inspected for bleeding again. This continued in 1 minute pressure intervals.
The following results were obtained:
Significantly, there were no significant adverse events or complications (including intimal dissection, acute vessel closure, thrombosis, retroperitoneal hemorrhage, thickening of the perivascular tissues, neural damage, infection, venous thrombosis, or pericatheter clot) and diagnostic or interventional procedures were successfully performed on all patients.
An excised pig heart having generally irregular surfaces was fitted with a hose connection and pressurized with water to 80 mmHg using a hand-pumped garden sprayer with an on/off valve and a pressure gauge from a blood pressure arm cuff. A biopsy needle that accommodated a 0.035″ guidewire was used to perform the initial needle stick. A 0.035″ guidewire was introduced through the needle and the needle was then removed. A 7 F catheter that accepts the 0.035″ guidewire was advanced and inserted into the tissue. The 7 F catheter and the 0.035″ guidewire were then removed and the path was checked for leakage, where it was noted that leakage occurred. The septum was identified and the needle was inserted from the epicardium through the septum and into the right ventricle, forming an angled tract in tissue as described above. The guidewire was passed through the tricuspid valve and into the superior vena cava (which was fitted with a silicone tube). A 7 F catheter with a tapered tip was then inserted and removed. No noticeable leakage occurred, indicating that the tract had sealed almost instantaneously. The steps were essentially repeated, through a free wall of a left ventricle. The straight through tract leaked, while the angled tract did not.
An intact pig stomach was pressurized using a pressurized water canister with an on/off valve connected to, the esophagus. Pressure was monitored with a blood pressure cuff gauge (fitted to the small intestine). A hose extension was passed through the stomach to bypass the pyloric sphincter in order to ensure an accurate pressure reading. The pressure ranged between 4-6 mm Hg based on water filling stomach with no additional pressurization, to 8 mm Hg. A biopsy needle was advanced to create a shallow angled needle stick along the greater curvature of the stomach. A 0.035″ guidewire was introduced into the needle, and the needle was then removed, leaving the guidewire in place. A 7 F catheter was inserted over the guidewire and advanced across the stomach wall to form an angled tract as described above. The stomach tissue had an irregular and tough surface and the catheter had to be rotated to advance the catheter through the stomach wall. The catheter and guidewire were removed, and no leakage was observed, indicating the tract sealed almost instantaneously. The pressure was then increased to 60 mm Hg by pressing firmly on the stomach with a hand, and still there was no visible leak. The steps were then repeated with a 16 F catheter and no leakage was observed at 6 mm Hg, 20 mm Hg, or 60 mm Hg. A straight through tract was made using a needle accommodating a 0.035″ guidewire as described in the example just above, and significant leakage was noted.
The present application is a continuation of pending U.S. patent application Ser. No. 11/873,957, filed Oct. 17, 2007, the priority of which is claimed under 35 U.S.C. §120, and the contents of which is incorporated herein by reference in its entirety, as though set forth in full.
Number | Date | Country | |
---|---|---|---|
Parent | 11873957 | Oct 2007 | US |
Child | 13289997 | US |